Active ingredientBrimonidineCat. No. P-B109-001CAS 59803-98-4Family · Pharmaceutical analytical standards
Brimonidine
An alpha-2 adrenergic agonist used as eye drops to lower eye pressure in open-angle glaucoma and ocular hypertension, approved in the United States in 1996. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It found a second life in dermatology: in 2013 the FDA approved a brimonidine gel that narrows small skin vessels and reduces facial redness in rosacea.
Go to the active ingredient →Active ingredientBrimonidineCat. No. P-B109-001CAS 59803-98-4
Active ingredientBrimonidine TartrateCat. No. P-B109-002CAS 70359-46-5
Pharmacopoeial impurityBrimonidine EP Impurity BCat. No. P-B109-003CAS 50358-63-9
Pharmacopoeial impurityBrimonidine EP Impurity CCat. No. P-B109-004CAS 6298-37-9
Pharmacopoeial impurityBrimonidine EP Impurity DCat. No. P-B109-005CAS 842138-74-3
Pharmacopoeial impurityBrimonidine EP Impurity ECat. No. P-B109-006CAS 168329-48-4
Pharmacopoeial impurityBrimonidine EP Impurity FCat. No. P-B109-007CAS 151110-15-5
Pharmacopoeial impurityBrimonidine EP Impurity GCat. No. P-B109-008CAS 1216379-05-3
Pharmacopoeial impurityBrimonidine EP Impurity G HClCat. No. P-B109-009
Pharmacopoeial impurityBrimonidine EP Impurity G Trifluoroacetic Acid SaltCat. No. P-B109-010CAS 1391054-10-6
Pharmacopoeial impurityBrimonidine EP Impurity HCat. No. P-B109-011CAS 91147-46-5
Pharmacopoeial impurityBrimonidine Tartrate EP Impurity ACat. No. P-B109-012CAS 91147-43-2
Isotopically labelledBrimonidine-d4Cat. No. P-B109-013CAS 1184971-51-4
NitrosamineN1,N2-Dinitroso BrimonidineCat. No. P-B109-016
NitrosamineN1-Nitroso BrimonidineCat. No. P-B109-017
ImpurityBrimonidine Impurity 1Cat. No. P-B109-019CAS 134892-47-0
ImpurityBrimonidine Impurity 2Cat. No. P-B109-020CAS 2768536-87-2![1H-Pyrazolo[3,4-b]quinoxalin-3-amine](https://img.vitasanlabs.com/vsl-struct/P-B109-021.svg?v=41e934f030)
Impurity1H-Pyrazolo[3,4-b]quinoxalin-3-amineCat. No. P-B109-021CAS 40254-90-8
Impurity6-isothiocyanatoquinoxalineCat. No. P-B109-022CAS 135306-56-8
ImpurityBrimonidine Impurity 3Cat. No. P-B109-023CAS 2768536-86-1
ImpurityAcetyl brimonidineCat. No. P-B109-024CAS 1158184-23-6
ImpurityBrimonidine 2,3-Dione Impurity hydrochlorideCat. No. P-B109-025
ImpurityBrimonidine Acrylate ImpurityCat. No. P-B109-026
ImpurityBrimonidine Cyclic ImpurityCat. No. P-B109-027
Active ingredientBrimonidine D-TartrateCat. No. P-B109-028CAS 1400635-36-0
ImpurityBrimonidine Degradation Impurity BCat. No. P-B109-029
ImpurityBrimonidine DimerCat. No. P-B109-030
ImpurityBrimonidine Impurity 4Cat. No. P-B109-032CAS 134892-42-5
ImpurityBrimonidine Impurity 5Cat. No. P-B109-040
ImpurityBrimonidine N-aspartic Acid ImpurityCat. No. P-B109-041
ImpurityBrimonidine Impurity 6Cat. No. P-B109-042
ImpurityBrimonidine Impurity 7Cat. No. P-B109-043
ImpurityBrimonidine Impurity 8Cat. No. P-B109-044
ImpurityBrimonidine Impurity 9Cat. No. P-B109-045CAS 934548-66-0
ImpurityN-(1H-imidazol-2-yl)quinoxalin-6-amineCat. No. P-B109-046CAS 185312-10-1
ImpurityN-(5-Bromoquinoxalin-6-yl)cyanamideCat. No. P-B109-047CAS 182628-02-0No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceBrimonidine tartrate CRSEDQM code Y0001658Family BrimonidineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.